The prevalence of rheumatoid arthritis: a systematic review of population-based studies

KB Almutairi, JC Nossent, DB Preen, HI Keen… - The Journal of …, 2021 - jrheum.org
Objective To estimate the prevalence of rheumatoid arthritis (RA) from international
population-based studies and investigate the influence of prevalence definition, data …

Risk of mortality in patients with giant cell arteritis: a systematic review and meta-analysis

CL Hill, RJ Black, JC Nossent, C Ruediger… - Seminars in arthritis and …, 2017 - Elsevier
Background Previous studies of mortality associated with GCA have shown conflicting
results. We conducted a systematic review and meta-analysis to determine the mortality risk …

Increased mortality in ankylosing spondylitis is related to disease activity

G Bakland, JT Gran, JC Nossent - Annals of the rheumatic diseases, 2011 - ard.bmj.com
Background The onset of disease in ankylosing spondylitis (AS) is generally earlier than in
other joint diseases, exposing patients to a prolonged burden of disease. Whether this is …

Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre

E Besada, W Koldingsnes, JC Nossent - Rheumatology, 2013 - academic.oup.com
Objective. Rituximab (RTX) is an anti-CD20 antibody used successfully in granulomatosis
with polyangiitis (GPA) for induction and maintenance of remission. Our study aims to …

Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality.

C Nikolaisen, Y Figenschau, JC Nossent - The Journal of rheumatology, 2008 - jrheum.org
OBJECTIVE: Anemia of chronic disease (ACD) is the most common extraarticular
manifestation of rheumatoid arthritis (RA), but there is limited information on the cause and …

Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with …

E Besada, W Koldingsnes, JC Nossent - Rheumatology, 2014 - academic.oup.com
Objective. Rituximab (RTX) is a B cell depleting agent used to induce and maintain
remission in patients with granulomatosis with polyangiitis (GPA). As the development of …

Levels of transforming growth factor-β are low in systemic lupus erythematosus patients with active disease

A Becker-Merok, GŲ Eilertsen, JC Nossent - The Journal of …, 2010 - jrheum.org
Objective. Cytokines are central regulators of the immune response but the workings of this
complex network in systemic lupus erythematosus (SLE) are not fully understood. We …

Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.

W Koldingsnes, JC Nossent - The Journal of Rheumatology, 2003 - jrheum.org
OBJECTIVE: To describe the course of disease activity and determine predictors of
remission and relapse in a population based cohort of patients with Wegener's …

Assessment of SpondyloArthritis International Society criteria for axial spondyloarthritis in chronic back pain patients with a high prevalence of HLA–B27

G Bakland, R Alsing, K Singh… - Arthritis care & …, 2013 - Wiley Online Library
Abstract Objective The Assessment of SpondyloArthritis international Society (ASAS)
classification criteria for axial spondyloarthritis (SpA) allow SpA classification of HLA–B27 …

[HTML][HTML] Mortality trends among patients with rheumatoid arthritis in Western Australia

KB Almutairi, CA Inderjeeth, DB Preen, HI Keen… - Rheumatology and …, 2023 - Springer
Introduction With scarce comparative data on mortality in Australian patients with rheumatoid
arthritis (RA), we investigated temporal changes in standardized mortality rates for patients …